Signifor LAR 40 MG

Ended Awarded Last action

Contract number
36C24525N0281
Awardee
Awarding agency
Obligated
$22,438

Award facts

Contract value 100% obligated
$22,438.42 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Bartlett, TN 38134, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 $816
Original award $21,622

About this award

This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Recordati Rare Diseases Inc., a division of the international pharmaceutical company Recordati Group. The $22,438.42 firm fixed-price delivery order is for the provision of SIGNIFOR LAR 40 MG, an orphan drug used to treat Cushing's disease and acromegaly. The contract is issued under Recordati's existing $15.6 million Federal Supply Schedule (FSS-61-IB) contract with the VA, as well as a $3.1 million Blanket Purchase Agreement with the agency. These indefinite-delivery vehicles enable the VA to efficiently access Recordati's portfolio of rare disease treatments, including Signifor LAR, Carbaglu, Cystadane, Isturisa, and Cystadrops, in support of comprehensive healthcare services for veterans. The contract does not have a set-aside designation, reflecting the specialized nature of Recordati's pharmaceutical offerings as a unique provider of these orphan drugs.

Quick answers

Who was awarded contract 36C24525N0281?

36C24525N0281 was awarded to Recordati Rare Diseases Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on December 31, 2024.

How much is contract 36C24525N0281 worth?

The government has obligated $22,438 on 36C24525N0281.

Is contract 36C24525N0281 an order under another contract?

Yes. 36C24525N0281 is a delivery order under 36F79721D0141, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24525N0281 competed?

The extent of competition for 36C24525N0281 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award